CompletedNot applicableNCT01586169
Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination
Studying Filariasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre d'Appui à la lutte contre la Maladie
- Principal Investigator
- Samba O Sow, MD, MPHCNAM, Mali
- Intervention
- triple co administration at once of the combination of Albendazole + ivermectin + azithromycin(drug)
- Enrollment
- 3000 enrolled
- Eligibility
- 5-65 years · All sexes
- Timeline
- 2010 – 2010
Study locations (1)
- Centre National D'Appui a la lutte contre la Maladie, Bamako, Mali, Mali
Collaborators
International Trachoma Initiative
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01586169 on ClinicalTrials.govOther trials for Filariasis
Additional recruiting or active studies for the same condition.